ASTROTECH Corp Debt Securities, Available-for-sale, Amortized Cost
ASTROTECH Corp (ASTC) had Debt Securities, Available-for-sale, Amortized Cost of $4.29 million as of 2026-03-31, per its 10-Q/A filed 2026-08-06.
Financial Statements › Notes
us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis · last filed 2026-08-06
- 2026-03-31: Debt Securities, Available-for-sale, Amortized Cost $4.29M.
- 2025-12-31: Debt Securities, Available-for-sale, Amortized Cost $7.58M.
- 2025-09-30: Debt Securities, Available-for-sale, Amortized Cost $12.01M.
- 2025-06-30: Debt Securities, Available-for-sale, Amortized Cost $15.97M.
| Period end | Debt Securities, Available-for-sale, Amortized Cost |
|---|---|
| 2026-03-31 | $4.29M 10-Q/A · filed 2026-08-06 |
| 2025-12-31 | $7.58M 10-Q · filed 2026-02-13 |
| 2025-09-30 | $12.01M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $15.97M 10-Q/A · filed 2026-08-06 |
| 2025-03-31 | $19.00M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $22.61M 10-Q · filed 2025-02-14 |
| 2024-09-30 | $22.65M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $22.65M 10-K · filed 2025-09-26 |
| 2024-03-31 | $27.36M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $27.36M 10-Q · filed 2024-02-13 |
| 2023-09-30 | $27.37M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $29.37M 10-K · filed 2024-09-20 |
| 2023-03-31 | $31.10M 10-Q · filed 2023-05-12 |
| 2022-12-31 | $32.52M 10-Q · filed 2023-02-13 |
| 2022-09-30 | $32.24M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $27.37M 10-K · filed 2023-09-28 |
| 2022-06-22 | $27.37M 10-K · filed 2022-09-15 |
| 2022-03-31 | $27.37M 10-Q · filed 2022-05-13 |
| 2021-12-31 | $27.37M 10-Q · filed 2022-02-14 |
| 2021-09-30 | $27.37M 10-Q · filed 2021-11-12 |
| 2021-06-30 | $27.37M 10-K · filed 2022-09-15 |
| 2018-06-30 | $3.63M 10-K · filed 2019-09-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |